The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 354:1489-1496 April 6, 2006 Number 14
NextNext

Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke
Douglas B. Gould, Ph.D., F. Campbell Phalan, B.A., Saskia E. van Mil, M.Sc., John P. Sundberg, Ph.D., Katayoun Vahedi, M.D., Pascale Massin, M.D., Marie Germaine Bousser, M.D., Peter Heutink, Ph.D., Jeffrey H. Miner, Ph.D., Elisabeth Tournier-Lasserve, M.D., and Simon W.M. John, Ph.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Commentary
-Perspective
 by Greenberg, S. M.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
SUMMARY

Small-vessel diseases of the brain underlie 20 to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. In this report, we show that a mutation in the mouse Col4a1 gene, encoding procollagen type IV {alpha}1, predisposes both newborn and adult mice to intracerebral hemorrhage. Surgical delivery of mutant mice alleviated birth-associated trauma and hemorrhage. We identified a COL4A1 mutation in a human family with small-vessel disease. We concluded that mutation of COL4A1 may cause a spectrum of cerebrovascular phenotypes and that persons with COL4A1 mutations may be predisposed to hemorrhage, especially after environmental stress.


Source Information

From the Howard Hughes Medical Institute (D.B.G., F.C.P., S.W.M.J.) and the Jackson Laboratory (D.B.G., F.C.P., J.P.S., S.W.M.J.) — both in Bar Harbor, Me.; the Department of Human Genetics, Section of Medical Genomics, VU University Medical Center, and the Center for Neurogenomics and Cognitive Research, VU University and VU University Medical Center, Amsterdam (S.E.M., P.H.); Service de Neurologie (K.V., M.G.B.) and Service d'Ophtalmologie (P.M.), Assistance Publique des Hôpitaux de Paris, Hôpital Lariboisière, Paris; INSERM Unité 740 and Laboratoire de Génétique, Assistance Publique des Hôpitaux de Paris, Paris (M.G.B., E.T.-L.); the Renal Division, Washington University School of Medicine, St. Louis (J.H.M.); and the Department of Ophthalmology, Tufts University School of Medicine, Boston (S.W.M.J.).

Address reprint requests to Dr. John at the Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609, or at swmj{at}jax.org.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.